Search Results 971-980 of 17809 for monoclonal antibody
... monoclonal antibody reversed the therapeutic effect of IVIG. Protection was associated with the ability of IVIG administration to induce surface expression ...
Clinical Trials · Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis · More about research at ...
Researchers also tested monoclonal antibodies to block or neutralize the IL-4 protein. They found that it also rejuvenated CAR-T cells and their ability to ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
PHOENIX — Mayo Clinic researchers are studying a new class of immunotherapy drugs called "bispecific antibodies" that have demonstrated potent tumor-killing ...
About this study. The study is being done to identify how many Healthcare workers develop antibodies against the SARS-CoV 2 virus over a 6 month period ...
... antibody-mediated rejection (AMR) at Week 52. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
About this study. The purpose of this study is to determine the safety profile, maximum tolerable dose (MTD) and cohort expansion of single-agent GBR 1342 ...
Anti-gm-csf monoclonal antibody treatment of chronic myelomonocytic leukemia treatment of Covid-19. Drugs of the Future. 2022 Dec; 47 (12):887-92; Drummond ...
Within 4 weeks (28 days): systemic cytotoxic chemotherapy; small molecule targeted agents with half-life ≥ 7 days; monoclonal antibodies, antibody-drug ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!